Evidence map›Paper›PMID 21593499›Full record

Trial reportThe American journal of clinical nutrition2011

Long-term effect of low-dose folic acid intake: potential effect of mandatory fortification on the prevention of neural tube defects.

Lisa A Houghton, Andrew R Gray, Meredith C Rose, Jody C Miller, Nicola A Hurthouse, Jesse F Gregory

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in The American journal of clinical nutrition, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Revised D-A-CH intake recommendations for folate: how much is needed?European journal of clinical nutrition · 2014
    Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lisa A HoughtonDepartments of Human Nutrition and Preventive and Social Medicine, University of Otago, Dunedin, New Zealand. lisa.houghton@otago.ac.nz
Andrew R Gray
Meredith C Rose
Jody C Miller
Nicola A Hurthouse
Jesse F Gregory

Funding

Vitamin B6 Effects on One-Carbon MetabolismR01DK072398 · NIDDK · UNIVERSITY OF FLORIDA · PI GREGORY, JESSE F. · 2005 to 2013
$3.3M
NIDDK NIH HHS R01 DK072398
6 · The paper itself

Abstract

backgroundUnderstanding the full effect of chronic low-dose folic acid is important in interpreting the effect of the mandatory folic acid fortification program in North America.

objectiveWe aimed to describe the rate of attainment and steady state (plateau) of red blood cell (RBC) folate in response to long-term intake of 140 μg (designed to mimic fortification) and 400 μg (recommended dose for the primary prevention of neural tube defects) folic acid/d in reproductive-aged women living in a country with minimal fortification.

designOn the basis of pharmacokinetics principles, it was recently proposed that a steady state should be reached after 40 wk. Thus, 144 women aged 18-40 y were randomly assigned to receive a daily folic acid supplement of 140 (n = 49) or 400 (n = 48) μg or placebo (n = 47) for 40 wk. RBC folate was measured at baseline and at 6, 12, 29, and 40 wk.

resultsAfter 40 wk, RBC folate did not reach a plateau in either treatment group. Kinetic modeling of the data indicated that RBC folate would approximately double from 779 to 1356 nmol/L in response to 140 μg folic acid/d with only ≈50% of model-estimated steady state conditions achieved at 40 wk. An average RBC folate concentration of 1068 nmol/L after 12 wk of supplementation with 400 μg folic acid/d was readily achieved at 36 wk after continuous intake of 140 μg/d.

conclusionOur model shows the considerable length of time required to attain the full effect of low-dose folic acid, which suggests that 140 μg folic acid/d could be as effective as 400 μg folic acid/d taken during the periconceptional period if given sufficient time. This trial is registered at www.anzctr.org.au as ACTRN12609000215224.

Indexed as

Food, FortifiedAdolescentAdultDouble-Blind MethodErythrocytesFemaleFolic AcidHumansNeural Tube DefectsYoung AdultFolic Acid

Identifiers

PMID21593499
PMCPMC3738376

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.